Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from ...

Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the publication of a new retrospective cohort study in Global Spine Journal demonstrating that 3D preoperative planning ...

The abrupt change in the U.S. childhood vaccine schedule from 17 vaccines to 11 belies promises to the American people that ...

Godrej Consumer Products expects double-digit consolidated revenue and EBITDA growth in the October-December quarter, led by ...

(HealthDay News) — Zoliflodacin is noninferior to ceftriaxone plus azithromycin for the treatment of uncomplicated urogenital gonorrhea, according to a study published online Dec. 11 in The Lancet.

Godrej Consumer Products Ltd on Tuesday said demand conditions in India strengthened progressively during the third quarter ...

Craig Morgan outlines why comparator clinical trials are useful and provides points to consider to ensure the best outcome. In clinical trials, a comparator drug (defined as ‘an investigational or ...

Godrej Consumer Products Ltd (GCPL) anticipates gradual consumption improvement, driven by falling inflation and lower GST ...

A simple, speedy single-slope ADC with a biphasic conversion cycle and a decent accuracy. Read on to learn more!

Both Phase 3 trials met all primary and secondary endpoints with high statistical significance in patients with moderate-to-severe plaque ...

A positive top-line readout from a phase 3 trial has emboldened Incyte to seek the FDA’s blessing for the company’s Monjuvi ...

Investing.com -- Polyrizon Ltd (NASDAQ:PLRZ) stock gained 2.8% on Monday after the pre-clinical-stage biotechnology company announced positive results from an in-vitro study of its PL-14 Allergy ...